• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Patient Factors Influencing Antibiotic Selection in Uncomplicated UTIs

Opinion
Video

Panelists discuss how fluoroquinolones are generally reserved for uncomplicated urinary tract infections (UTIs) only when first-line options are contraindicated or pathogen resistance is confirmed, with treatment duration ranging from single-dose fosfomycin to 3 to 5 days for most antibiotics and 7 to 10 days for nitrofurantoin, noting shorter regimens typically achieve 85% to 95% adherence rates compared with 60% to 75% for longer courses, significantly affecting treatment success, particularly when patient factors such as adverse effects, dosing complexity, and lifestyle disruptions are considered.

Video content above is prompted by the following:

  • In which clinical scenarios would the use of other therapies, such as fluoroquinolones, be recommended for treating uncomplicated UTIs, and what factors guide the decision to choose these over preferred treatments?
  • How does the duration of therapy differ across treatment options, and how does this affect patient adherence rates and treatment success?
Related Videos
Galen Shearn-Nance, BS
4 experts are featured in this series.
5 experts are featured in this series
4 experts are featured in this series.
Dr Johnie Rose
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Andrew Evens, DO
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Related Content
MASLD significantly increases the risk of severe infection, a literature review suggests. | Image credit: SewcreamStudio - stock.adobe.com

MASLD Associated With 2-Fold Increase of Serious Bacterial Infection

April 12th 2025
Article

Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were evaluated in a new review.

Read More

managed care cast logo

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

December 23rd 2024
Podcast

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Listen

None of the eteplirsen-treated patients reached an LVEF below 50%, compared with 22.1% of patients in the control group. | Image credit: inthasone - stock.adobe.com

Eteplirsen Treatment Linked to Slower Cardiac Decline in DMD

April 11th 2025
Article

None of the eteplirsen-treated patients reached a left ventricular ejection fraction below 50% compared with 22.1% of patients in the control group.

Read More

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

December 17th 2024
Podcast

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

Listen

Human brain illustration | Image Credit: Siarhei - stock.adobe.com

Inflammatory Diets Raise Risk of Brain Disorders

April 10th 2025
Article

Vegetables, fish oil, fruit, and high-fiber foods have anti-inflammatory effects, while low-fiber bread and animal fats are associated with pro-inflammatory effects. Diets heavier on these pro-inflammatory foods may be associated with higher risks of brain disorders.

Read More

Novartis worker | Image credit: Novartis

Will the Coming Radiopharmaceutical Wave Reach More Patients With Cancer?

April 10th 2025
Article

This article appears in the April issue of Evidence-Based Oncology.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.